2'-核糖改性核酸:一种减少寡核酸药物的脱效应的策略
Honglei Zhang1,2, Yangjian Liu2, Jingxuan Ma1
1Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd., Beijing 100176, P.R. China.
Molecular therapy. Nucleic acids
|February 6, 2026
概括
对寡核酸药物的新化学修改提高了基因沉默的有效性,并减少了意外的影响. 这些2'-ribose修饰增强了各种疾病的治疗潜力.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 基于寡聚核酸的治疗方法具有前景,但在代谢稳定性和非目标效应方面面临挑战.
- 化学修饰对于提高寡核类药物的性能和安全性至关重要.
研究的目的:
- 设计和合成用于寡核酸药物的新型2eal位置核糖酶修饰物.
- 评估这些修改对siRNA生物物理和生物特性的影响.
- 评估减少非目标效应和增强基因沉默功效的潜力.
主要方法:
- 合成新型的2个转基因单核酸.
- 在小干扰RNAs (siRNAs) 的反意义链中纳入改性核酸.
- 评估双重热稳定性,体外基因沉默活性 (PCSK9) 和非目标效应.
主要成果:
- 新的2个eal-ribose修饰被成功合成并纳入siRNAs.
- 虽然热稳定性下降,但体外对PCSK9基因的基因沉默活性显著增强.
- 与常规修改 (2 eal-O-甲基和 2 eal-O-) 相比,有效减轻了非目标效应.
结论:
- 新设计的2eal-ribose修饰可以显著提高siRNA基因沉默功效.
- 这些修改有效地减少了非目标效应,提高了寡核酸治疗药物的安全性.
- 基因沉默疗法的临床前和临床应用中,2eal-ribose-modified核酸具有前景.
更多相关视频
相关概念视频
Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Riboswitches
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...


